Interactive Session - Aggressive or Delayed Management of the Klinefelter Adolescent: What Do the Data Show? An Interactive Debate
Time:1:15 pm - 2:15 pm
Location:HCC312 - Hawaii Convention Center
Peter N. Schlegel, M.D. (Chair), Weill Cornell Medical College
Darius A. Paduch, M.D., Weill Cornell Medical College
Robert D. Oates, M.D., Boston Medical Center
Needs Assessment and Description
This interactive session for clinicians and researchers
involved in male fertility care will provide expert review of
the potential for early treatment of Klinefelter syndrome
in adolescents to improve future fertility as well as the
potential developmental benefits of androgen therapy.
Results of early intervention with hormonal therapy and
sperm retrieval will be presented. The risks and results of
such treatment of adult males with Klinefelter syndrome
will be discussed, and the limitations of current published
literature will be reviewed in an interactive format with
At the conclusion of this session, participants should be
- Discuss results of early vs. late fertility treatment for
males with Klinefelter syndrome.
- Identify developmental issues that can be affected by
androgen therapy in the Klinefelter male.
In a 28-year-old male with Klinefelter syndrome,
aromatase inhibitor therapy is most likely to:
a. Increase estradiol.
b. Decrease FSH.
c. Increase testosterone.
d. Improve sperm retrieval rates.